Advanced search
1 file | 105.82 KB Add to list

A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer

(2010) ONCOLOGY. 78(3-4). p.267-270
Author
Organization
Keywords
Toxicity, Chemotherapy, Non-small cell lung cancer, CLINICAL-TRIALS, Gemcitabine, Carboplatin, CISPLATIN, METAANALYSIS, GEMCITABINE/CARBOPLATIN, CHEMOTHERAPY, TOXICITY

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 105.82 KB

Citation

Please use this url to cite or link to this publication:

MLA
Surmont, Veerle, et al. “A Randomized Phase II Study Comparing Two Schedules of the 21-Day Regimen of Gemcitabine and Carboplatin in Advanced Non-Small Cell Lung Cancer.” ONCOLOGY, vol. 78, no. 3–4, 2010, pp. 267–70, doi:10.1159/000315733.
APA
Surmont, V., Aerts, J., van Klaveren, R., Tournoy, K., Tan, K., Vernhout, R., … van Meerbeeck, J. (2010). A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer. ONCOLOGY, 78(3–4), 267–270. https://doi.org/10.1159/000315733
Chicago author-date
Surmont, Veerle, JGJV Aerts, RJ van Klaveren, K Tournoy, KY Tan, RM Vernhout, PIM Schmitz, C Legrand, HC Hoogsteden, and JP van Meerbeeck. 2010. “A Randomized Phase II Study Comparing Two Schedules of the 21-Day Regimen of Gemcitabine and Carboplatin in Advanced Non-Small Cell Lung Cancer.” ONCOLOGY 78 (3–4): 267–70. https://doi.org/10.1159/000315733.
Chicago author-date (all authors)
Surmont, Veerle, JGJV Aerts, RJ van Klaveren, K Tournoy, KY Tan, RM Vernhout, PIM Schmitz, C Legrand, HC Hoogsteden, and JP van Meerbeeck. 2010. “A Randomized Phase II Study Comparing Two Schedules of the 21-Day Regimen of Gemcitabine and Carboplatin in Advanced Non-Small Cell Lung Cancer.” ONCOLOGY 78 (3–4): 267–270. doi:10.1159/000315733.
Vancouver
1.
Surmont V, Aerts J, van Klaveren R, Tournoy K, Tan K, Vernhout R, et al. A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer. ONCOLOGY. 2010;78(3–4):267–70.
IEEE
[1]
V. Surmont et al., “A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer,” ONCOLOGY, vol. 78, no. 3–4, pp. 267–270, 2010.
@article{1186503,
  author       = {{Surmont, Veerle and Aerts, JGJV and van Klaveren, RJ and Tournoy, K and Tan, KY and Vernhout, RM and Schmitz, PIM and Legrand, C and Hoogsteden, HC and van Meerbeeck, JP}},
  issn         = {{0030-2414}},
  journal      = {{ONCOLOGY}},
  keywords     = {{Toxicity,Chemotherapy,Non-small cell lung cancer,CLINICAL-TRIALS,Gemcitabine,Carboplatin,CISPLATIN,METAANALYSIS,GEMCITABINE/CARBOPLATIN,CHEMOTHERAPY,TOXICITY}},
  language     = {{eng}},
  number       = {{3-4}},
  pages        = {{267--270}},
  title        = {{A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer}},
  url          = {{http://doi.org/10.1159/000315733}},
  volume       = {{78}},
  year         = {{2010}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: